TDP2


Description

The TDP2 (tyrosyl-DNA phosphodiesterase 2) is a protein-coding gene located on chromosome 6.

TDP2 is a DNA repair enzyme that removes various covalent adducts from DNA by hydrolyzing a 5'-phosphodiester bond, producing DNA with a free 5' phosphate. It catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase 2 (TOP2) active site tyrosine residue. This 5'-tyrosyl DNA phosphodiesterase activity allows the repair of TOP2-induced DNA double-strand breaks (DSBs) without requiring nuclease activity, generating 'clean' DSBs with 5'-phosphate termini ready for ligation. This protects the transcription of genes involved in neurological development and maintenance from TOP2's abortive activity. TDP2 hydrolyzes 5'-phosphoglycolates on protruding 5' ends on DSBs caused by radiation and free radicals. It prefers single-stranded DNA or duplex DNA with a 4 base pair overhang as a substrate. TDP2 acts as a regulator of ribosome biogenesis following stress. It also has 3'-tyrosyl DNA phosphodiesterase activity, but less efficiently and slower than TDP1. TDP2 is the major, if not the only, 5'-tyrosyl-DNA phosphodiesterase in cells. TDP2 functions as an adapter in the specific activation of MAP3K7/TAK1 in response to TGF-beta. It associates with components of the TGF-beta receptor-TRAF6-TAK1 signaling module and promotes their ubiquitination-dependent complex formation. TDP2 is involved in non-canonical TGF-beta-induced signaling pathways. It may also negatively regulate ETS1 and inhibit NF-kappa-B activation.

TDP2 is also known as AD022, EAP2, EAPII, TTRAP, dJ30M3.3, hTDP2.

Associated Diseases


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.